A Series A diligence costs $50–200K and still misses the regulatory and quality risk — the place where value actually dies. Valar gives you a structured, cited diligence memo on every deal: readiness scores, red flags, vendor review, and an evidence trail. In days, not weeks.
Founder trust is what makes diligence possible. The company publishes a version-locked snapshot — deliberately, explicitly. That snapshot is everything you see, and everything you'll ever see.
One engine, both sides of the table.
From Istari — or from an uploaded data room — the company publishes a version-locked diligence package. Explicit, deliberate, audit-logged.
Five specialist analysts read the package: regulatory pathway, quality and CMC, nonclinical, and ex-US. Every finding cited to its source.
Readiness scores, red flags, vendor review, evidence trace — in a read-only review workspace. Days, not weeks.
Above the Istari stand the Valar — the Powers. Builders get counselors; investors judge. Every diligence memo is deliberated by five specialist analysts, each signing off on their domain, each finding attributed by name.
The wisest counselor. Reads the whole program and tells you the story the data actually supports.
Master of craft. Interrogates the quality system, the CMC package, and every vendor dossier.
Lore of living things. Checks whether the toxicology actually supports the clinical plan.
The two who journeyed into the East. Map what changes across the EU, Japan, and China.
Priced against the $50–200K a consultant-led diligence costs today — not against software seats. Pilot pricing below; final pricing validated with pilot funds.
We're piloting with a select group of funds. The wedge: we run a parallel diligence on your live deal — free — measured against your current process on time and cost.
Request a pilot